Kalobios Pharmaceuticals Inc (KBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KBIO | TEVA | RDY | BBIO | BHC |
| Company | Kalobios Pharmaceuticals Inc | Teva Pharmaceutical Industries ADR | Dr. Reddy's Laboratories Ltd ADR | Bridgebio Pharma Inc | Bausch Health Companies Inc |
| Price Information | |||||
| Exchange | OTC US | NYSE | NYSE | NASDAQ | NYSE |
| Open | 1.6500 | 14.15 | 74.89 | 28.45 | 8.10 |
| High | 2.2000 | 14.16 | 75.43 | 28.78 | 8.23 |
| Low | 1.6200 | 13.96 | 74.71 | 27.17 | 7.74 |
| Last | 2.1900 | 13.98 | 75.21 | 27.83 | 7.82 |
| Change | +0.4630 | -0.10 | +0.43 | +0.09 | -0.27 |
| % Change | +26.81% | -0.71% | +0.58% | +0.32% | -3.34% |
| Volume | 29,900 | 7,051,200 | 224,200 | 1,677,200 | 3,396,600 |
| 20-Day Average Volume | 12,700 | 9,157,430 | 190,095 | 1,597,055 | 3,813,575 |
| Previous Close | 1.7270 | 14.08 | 74.78 | 27.74 | 8.09 |
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.7043 | 13.52 | 72.77 | 26.17 | 8.70 |
| 20-Day Raw Stochastic | 98.57% | 75.19% | 95.33% | 81.37% | 2.94% |
| 20-Day Relative Strength | 60.40% | 57.65% | 57.57% | 49.97% | 34.40% |
| Weighted Alpha | -53.96 | +69.16 | +23.92 | +12.35 | +2.84 |
| Today's Opinion | N/A | 80% Buy | 88% Buy | 64% Sell | 8% Sell |
| Previous Opinion | N/A | 80% Buy | 88% Buy | 64% Sell | 8% Sell |
| Last Month's Opinion | N/A | 100% Buy | 56% Buy | 56% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +36.88% since 07/28/17 | +1.23% since 04/26/24 | +0.89% since 04/26/24 | +11.86% since 04/26/24 | -10.22% since 04/26/24 |
| Low | 1.5700 on 08/02/17 | 13.70 on 05/01/24 | 73.38 on 05/01/24 | 24.95 on 04/30/24 | 7.74 on 05/03/24 |
| High | 2.2000 on 08/04/17 | 14.33 on 04/29/24 | 75.43 on 05/03/24 | 28.78 on 05/03/24 | 9.01 on 05/01/24 |
| 1-Month | |||||
| %Chg | +12.31% since 07/03/17 | -0.99% since 04/03/24 | +3.00% since 04/03/24 | -4.79% since 04/03/24 | -22.11% since 04/03/24 |
| Low | 1.5000 on 07/11/17 | 12.51 on 04/19/24 | 70.71 on 04/19/24 | 23.68 on 04/25/24 | 7.74 on 05/03/24 |
| High | 2.2000 on 08/04/17 | 14.47 on 04/08/24 | 75.43 on 05/03/24 | 29.65 on 04/04/24 | 10.48 on 04/05/24 |
| 3-Month | |||||
| %Chg | -5.60% since 05/04/17 | +13.84% since 02/02/24 | +4.18% since 02/02/24 | -17.93% since 02/02/24 | -1.26% since 02/02/24 |
| Low | 1.5000 on 07/11/17 | 11.83 on 02/09/24 | 70.71 on 04/19/24 | 23.68 on 04/25/24 | 7.68 on 02/05/24 |
| High | 2.9500 on 05/17/17 | 14.47 on 04/08/24 | 77.72 on 02/23/24 | 41.04 on 02/15/24 | 11.46 on 04/03/24 |
| 6-Month | |||||
| %Chg | -28.20% since 02/03/17 | +55.51% since 11/03/23 | +17.02% since 11/03/23 | -3.47% since 11/03/23 | +3.30% since 11/03/23 |
| Low | 1.5000 on 07/11/17 | 8.55 on 11/10/23 | 64.36 on 11/06/23 | 23.68 on 04/25/24 | 6.53 on 11/13/23 |
| High | 3.2500 on 02/17/17 | 14.47 on 04/08/24 | 77.72 on 02/23/24 | 44.32 on 12/28/23 | 11.46 on 04/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 32,806 | 15,672,894 | 12,550,895 | 5,207,800 | 2,857,522 |
| Shares Outstanding, K | 14,980 | 1,121,094 | 166,878 | 187,129 | 365,412 |
| Annual Sales | 0 | 15,846,000,000 | 2,992,000,000 | 9,300,000 | 8,757,000,000 |
| Annual Net Income | -27,010,000 | -559,000,000 | 548,000,000 | -643,200,000 | -592,000,000 |
| Last Quarter Sales | N/A | 4,457,000,000 | 865,780,000 | 1,750,000 | 2,408,000,000 |
| Last Quarter Net Income | N/A | 429,000,000 | 165,470,000 | -168,150,000 | -39,000,000 |
| 60-Month Beta | 2.99 | 1.04 | 0.57 | 1.08 | 0.90 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.00 on 01/31/24 | 0.99 on 01/31/24 | -0.20 on 05/02/24 | -0.17 on 05/02/24 |
| Latest Earnings Date | 09/22/17 | 05/08/24 | 05/07/24 | 05/02/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.072 on 11/27/17 | 0.410 on 07/28/23 | N/A | 1.000 on 11/10/10 |
| Next Ex-Dividends Date | N/A | 11/27/17 | 07/28/23 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 5.70 | 19.73 | 0.00 | 2.26 |